ResMed | RMD - Market Capitalization

Stock Price
230.61
Daily Change
-0.23 -0.10%
Monthly
-9.85%
Yearly
2.61%
Q1 Forecast
223.87

ResMed reported $34.05B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 4.72B 1.36B Mar/2026
Artivion USD 1.57B 616M Mar/2026
AtriCure USD 1.97B 215M Dec/2025
Baxter International USD 9.82B 1.87B Dec/2025
Cochlear AUD 13.02B 4.03B Mar/2026
Cooper Companies USD 14.7B 1.24B Mar/2026
CSL USD 71.32B 15.44B Mar/2026
Dexcom USD 25.88B 503M Dec/2025
Edwards Lifesciences USD 49.47B 3.81B Dec/2025
Fisher Paykel Healthcare NZD 22.48B 720.28M Mar/2026
Globus Medical USD 12.64B 954M Mar/2026
Haemonetics USD 3.76B 1.44B Dec/2025
Hologic USD 16.62B 1.67B Dec/2025
Idexx Laboratories USD 54.02B 2.91B Dec/2025
Insulet USD 20B 1.74B Dec/2025
Integra LifeSciences USD 967M 150M Dec/2025
Intuitive Surgical USD 200.77B 40.45B Dec/2025
Masimo USD 9.28B 2.44B Mar/2026
Philips EUR 22.38B 192.58M Dec/2025
Ramsay Health Care AUD 9.45B 1.52B Mar/2026
ResMed USD 35.16B 4.79B Dec/2025
Sigma Healthcare AUD 2.8B 1.88B Feb/2026
Steris USD 24.88B 511M Dec/2025
Teleflex USD 5.39B 91M Dec/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025